These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33384227)

  • 1. Targeted Therapies for Breast Cancer Brain Metastases.
    Cali Daylan AE; Leone JP
    Clin Breast Cancer; 2021 Aug; 21(4):263-270. PubMed ID: 33384227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Therapies for Brain Metastases from Breast Cancer.
    Venur VA; Leone JP
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
    McMullin RP; Wittner BS; Yang C; Denton-Schneider BR; Hicks D; Singavarapu R; Moulis S; Lee J; Akbari MR; Narod SA; Aldape KD; Steeg PS; Ramaswamy S; Sgroi DC
    Breast Cancer Res; 2014 Mar; 16(2):R25. PubMed ID: 24625110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current challenges in the management of breast cancer brain metastases.
    O'Sullivan CC; Davarpanah NN; Abraham J; Bates SE
    Semin Oncol; 2017 Apr; 44(2):85-100. PubMed ID: 28923217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtyping of brain metastases and implications for therapy.
    Renfrow JJ; Lesser GJ
    Curr Treat Options Oncol; 2013 Dec; 14(4):514-27. PubMed ID: 23907440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Brain and Leptomeningeal Metastases from Breast Cancer.
    Pellerino A; Internò V; Mo F; Franchino F; Soffietti R; Rudà R
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
    Larsen PB; Kümler I; Nielsen DL
    Cancer Treat Rev; 2013 Nov; 39(7):720-7. PubMed ID: 23481218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic treatment of brain metastases from breast cancer].
    Taillibert S; Conforti R; Bonneterre J; Bachelot T; Le Rhun E; Bernard-Marty C
    Cancer Radiother; 2015 Feb; 19(1):36-42. PubMed ID: 25662600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases.
    Parsai S; Miller JA; Juloori A; Chao ST; Kotecha R; Mohammadi AM; Ahluwalia MS; Murphy ES; Barnett GH; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    J Neurosurg; 2020 Feb; 132(2):503-511. PubMed ID: 30738402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.
    Ramakrishna N; Temin S; Chandarlapaty S; Crews JR; Davidson NE; Esteva FJ; Giordano SH; Kirshner JJ; Krop IE; Levinson J; Modi S; Patt DA; Perlmutter J; Winer EP; Lin NU
    J Clin Oncol; 2018 Sep; 36(27):2804-2807. PubMed ID: 29939840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
    Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Treatment Options for Breast Cancer Brain Metastases.
    Raghunath A; Desai K; Ahluwalia MS
    Curr Treat Options Oncol; 2019 Feb; 20(3):19. PubMed ID: 30771009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Sanctuary Site: Options when Breast Cancer Metastasizes to the Brain.
    Krishnan M; Krishnamurthy J; Shonka N
    Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
    Chamberlain MC; Baik CS; Gadi VK; Bhatia S; Chow LQ
    Neuro Oncol; 2017 Jan; 19(1):i1-i24. PubMed ID: 28031389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer.
    Peddi PF; Hurvitz SA
    J Neurooncol; 2014 Mar; 117(1):7-13. PubMed ID: 24469856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of breast cancer brain metastases.
    Takahashi H; Isogawa M
    Chin Clin Oncol; 2018 Jun; 7(3):30. PubMed ID: 30056732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging targeted therapies for metastatic breast cancer.
    Perez EA; Spano JP
    Cancer; 2012 Jun; 118(12):3014-25. PubMed ID: 22006669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and immunotherapeutic approaches in brain metastases.
    Ahluwalia MS; Winkler F
    Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Molecular Pathways in Intracranial Metastatic Disease.
    Venur VA; Cohen JV; Brastianos PK
    Front Oncol; 2019; 9():99. PubMed ID: 30886831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.